Milestones of Themis Medicare

1969

Establishment of Themis Chemicals (now Themis Medicare) in joint partnership with Gedeon Richter Ltd., Hungary

Gedeon Richter first established business relationship with Themis in 1969 when they became joint venture partners for the production of APIs and formulations.

Learn More

1971

Themis Chemicals becomes the Second Company in the world and First Company in India to produce Vitamin B12 by non-sterile fermentation.

1976

Themis Chemicals is the Second Company in the world and First Company in India to produce Ethambutol Dihydrochloride.

1985

Themis Chemicals produces RIFAMPICIN for the FIRST TIME in India

1998

Indigenously develops Simvastatin for the first time in Asia

1999

Launch of E MAL^TM Alpha Beta Arteether, a THEMIS-CDRI product, by the Prime Minister Shri Atal Bihari Vajpayee on Technology Day

2001

Themis Chemicals renamed THEMIS MEDICARE LIMITED

2002

Themis Medicare develops and introduces SEPGARD^TM, a unique wound healing agent, first time in India.

2006

Themis Joint Venture Richter Themis Medicare (India) Pvt.Ltd. commences production.

Themis Medicare Commences operations at Haridwar.

2013

Long-term partnership signed with Novartis India Limited for exclusive marketing rights of AQUADOL TPM Gel (Voveran TPM Gel) for India

Break through development of AQUADOL 75 mg / ml injection and assigning its exclusive marketing rights to Novartis India Limited under their flagship brand Voveran 75 mg / ml injection

2022

VIRALEX® - Inosine Pranobex, a unique Immunomodulator drug with broad spectrum antiviral action receives use approval from The Drug Controller General of India (DCGI) for the treatment of COVID-19 as a Prescription Only Medicine for restricted emergency use based on the results of the robust phase 2 and phase 3 RCTs conducted in India by Themis Medicare Limited.